About Aeris Biosciences
Aeris Biosciences is a private company based in Cleveland, Ohio, incorporated in 2022 in Delaware. It has reported $3,000,000 raised in one offering on Form D since May 2026. Its chief executive is Isaiah Kaiser.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 15, 2026 | $3,000,000of $4.0M target | 13 | $230K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aeris Biosciences's Form D filed May 15, 2026.